Stock comparison
JOHNSON & JOHNSON is 346.9x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($664.95 B vs $1.92 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
JNJ is larger
JOHNSON & JOHNSON is 346.9x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($664.95 B vs $1.92 B).
Market value leader
JNJ
JOHNSON & JOHNSON is 346.9x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($664.95 B vs $1.92 B).
Revenue leader
JNJ
HRMY: $868.45M vs JNJ: $94.19B.
Profit leader
JNJ
HRMY: $158.69M vs JNJ: $26.80B.
Margin leader
JNJ
HRMY: 18.3% vs JNJ: 28.5% net margin.
| Metric | HRMY | JNJ |
|---|---|---|
| Market cap | $1.92 B | $664.95 B |
| US-listed rank | #2121 | #17 |
| Revenue (latest FY) | $868.45M | $94.19B |
| Net income (latest FY) | $158.69M | $26.80B |
| Net margin | 18.3% | 28.5% |
| P/E (trailing FY) | 12.1x | 24.8x |
| SEC filings | 434 | 1,004 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
JOHNSON & JOHNSON is 346.9x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($664.95 B vs $1.92 B).
In their latest fiscal years, Harmony Biosciences Holdings, Inc. reported $868.45M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: Harmony Biosciences Holdings, Inc. and JOHNSON & JOHNSON, or browse the full rankings.